These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases]. Marone P, Concia E, Perversi L, Cruciani M. Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651 [Abstract] [Full Text] [Related]
10. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. Shannon K, Phillips I. J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451 [Abstract] [Full Text] [Related]
11. Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital. Markovska RD, Stoeva TJ, Bojkova KD, Mitov IG. Microb Drug Resist; 2014 Apr; 20(2):131-7. PubMed ID: 24171449 [Abstract] [Full Text] [Related]
12. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria. Rogers DT, Russell AD. J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086 [No Abstract] [Full Text] [Related]
13. Antibacterial activity of a new cephalosporin, cefotaxime. Russell AD, Rogers DT. J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429 [No Abstract] [Full Text] [Related]
14. Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species. Chandler SW, Nolte FS. Eur J Clin Microbiol; 1987 Aug; 6(4):476-8. PubMed ID: 3499317 [Abstract] [Full Text] [Related]
15. Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. Huber TW, Thomas JS. J Clin Microbiol; 1994 Oct; 32(10):2481-6. PubMed ID: 7814486 [Abstract] [Full Text] [Related]
16. Inactivation of cephalosporins by beta-lactamases of gram-negative rods. Bauernfeind A, Petermüller C, Jungwirth R. Infection; 1983 Oct; 11 Suppl 1():S39-43. PubMed ID: 6339417 [Abstract] [Full Text] [Related]
17. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, Woo GJ, Lee K. Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318 [Abstract] [Full Text] [Related]
18. Antibacterial antagonism of beta-lactam antibiotics in experimental infections. Kasai K. Chemotherapy; 1986 Apr; 32(2):148-58. PubMed ID: 3516593 [Abstract] [Full Text] [Related]
19. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives. Kojo H, Shigi Y, Nishida M. J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313 [Abstract] [Full Text] [Related]
20. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens. Park YJ, Yu JK, Lee S, Park JJ, Oh EJ. Ann Clin Lab Sci; 2007 Mar; 37(1):75-8. PubMed ID: 17311873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]